Accuray (ARAY) EBITDA Margin (2010 - 2026)
Accuray's (ARAY) quarterly EBITDA Margin came in at 8.67% in Q1 2026, down 976.0% year-on-year from 0.99% in Q1 2025, and up 23.38% quarter-over-quarter from 11.31% in Q4 2025.
Accuray (ARAY) EBITDA Margin (2010 - 2026) Analysis & Trends
Accuray's EBITDA Margin history runs 17 years deep, the most recent figure standing at 8.67% for Q1 2026.
- On a quarterly basis, EBITDA Margin fell 976.0% year-over-year to 8.67% in Q1 2026; TTM through Mar 2026 was 8.22%, a 1006.0% decrease from a year earlier, with the FY2025 full-year figure at 1.71%, up 160.0% from the prior year.
- EBITDA Margin rose to 8.67% in Q1 2026 per ARAY's latest filing, from 11.31% in the prior quarter.
- Across five years, EBITDA Margin topped out at 28.2% in Q2 2025 and bottomed at 12.04% in Q3 2025.
- The 5-year median for EBITDA Margin is 1.09% (2025), against an average of 3.23%.
- Across the five-year window, EBITDA Margin tumbled 1957 bps in 2022 and surged 838 bps in 2023, its largest moves.
- Year by year, EBITDA Margin stood at 2.36% in 2022, then plunged by 269 bps to 3.98% in 2023, then jumped by 181 bps to 3.22% in 2024, then slumped by 452 bps to 11.31% in 2025, then advanced by 23 bps to 8.67% in 2026.
- Per Business Quant, the three latest ARAY EBITDA Margin figures stand at 8.67% (Q1 2026), 11.31% (Q4 2025), and 12.04% (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 28.97% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 21.42% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 6.17% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.04% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Accuray | 29,832.96 | -38.50 Mn | 25.29 Mn | -8.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.67% |
| Dec 31, 2025 | -11.31% |
| Sep 30, 2025 | -12.04% |
| Jun 30, 2025 | 28.20% |
| Mar 31, 2025 | 1.09% |
| Dec 31, 2024 | 3.22% |
| Sep 30, 2024 | -2.12% |
| Jun 30, 2024 | 22.21% |
| Mar 31, 2024 | -2.02% |
| Dec 31, 2023 | -3.98% |
| Sep 30, 2023 | 4.07% |
| Jun 30, 2023 | 18.25% |
| Mar 31, 2023 | 0.86% |
| Dec 31, 2022 | 2.36% |
| Sep 30, 2022 | -4.30% |
| Jun 30, 2022 | 17.19% |
| Mar 31, 2022 | 1.91% |
| Dec 31, 2021 | 3.42% |
| Sep 30, 2021 | 15.27% |
| Jun 30, 2021 | 30.51% |